Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer

BACKGROUND: Lung immune prognostic index (LIPI) status was recently developed to predict responses to immune checkpoint inhibitor (ICI) treatments. However, it is unclear whether LIPI is a prognostic index for both patients treated with ICI monotherapy and patients treated with ICIs combined with ch...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Wang, Wenxian, Huang, Zhangzhou, Yu, Zongyang, Zhuang, Wu, Zheng, Weijun, Cai, Zhijian, Shi, Lei, Yu, Xinmin, Lou, Guangyuan, Hong, Wei, Zhang, Yiping, Chen, Ming, Song, Zhengbo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583465/
https://ncbi.nlm.nih.gov/pubmed/33163403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.572853
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia